These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10923282

  • 21. A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
    Foidart JM, Wuttke W, Bouw GM, Gerlinger C, Heithecker R.
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):124-34. PubMed ID: 10943575
    [Abstract] [Full Text] [Related]

  • 22. Drospirenone and its antialdosterone properties.
    Genazzani AR, Mannella P, Simoncini T.
    Climacteric; 2007 Feb; 10 Suppl 1():11-8. PubMed ID: 17364593
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.
    Huber J, Foidart JM, Wuttke W, Merki-Feld GS, The HS, Gerlinger C, Schellschmidt I, Heithecker R.
    Eur J Contracept Reprod Health Care; 2000 Mar; 5(1):25-34. PubMed ID: 10836660
    [Abstract] [Full Text] [Related]

  • 24. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC.
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [Abstract] [Full Text] [Related]

  • 25. Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration.
    Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M.
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1797-804. PubMed ID: 21411552
    [Abstract] [Full Text] [Related]

  • 26. Combined oral contraceptive pills containing desogestrel or drospirenone enhance large vessel and microvasculature vasodilation in healthy premenopausal women.
    Thompson AK, Przemska A, Vasilopoulou D, Newens KJ, Williams CM.
    Microcirculation; 2011 Jul; 18(5):339-46. PubMed ID: 21418384
    [Abstract] [Full Text] [Related]

  • 27. A study of cycle control, side effects and client's satisfaction of a low dose combined contraceptive containing ethinylestradiol/drospirenone (24/4 regimen).
    Chaiyasit N, Taneepanichskul S.
    J Med Assoc Thai; 2010 May; 93(5):517-22. PubMed ID: 20524436
    [Abstract] [Full Text] [Related]

  • 28. The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study.
    Fruzzetti F, Lello S, Lazzarini V, Fratta S, Orrù M, Sorge R, Minerba L, Ricci C, Genazzani AR, Melis GB, Paoletti AM.
    Contraception; 2007 Mar; 75(3):199-203. PubMed ID: 17303489
    [Abstract] [Full Text] [Related]

  • 29. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
    Rübig A.
    Climacteric; 2003 Oct; 6 Suppl 3():49-54. PubMed ID: 15018248
    [Abstract] [Full Text] [Related]

  • 30. The effect of a continuous regimen of drospirenone 3 mg/ethinylestradiol 30 microg on Cox-2 and Ki-67 expression in the endometrium.
    Maia H, Casoy J, Athayde C, Valente Filho J, Coutinho EM.
    Eur J Contracept Reprod Health Care; 2010 Feb; 15(1):35-40. PubMed ID: 20063991
    [Abstract] [Full Text] [Related]

  • 31. [Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial].
    Fan GS, Bian ML, Cheng LN, Cao XM, Huang ZR, Han ZY, Jing XP, Li J, Wu SY, Xiong CL, Xiong ZA, Yue TF.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):38-44. PubMed ID: 19563061
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone.
    Blode H, Klipping C, Richard F, Trummer D, Rohde B, Diefenbach K.
    Contraception; 2012 Feb; 85(2):177-84. PubMed ID: 22067789
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Drospirenone, a progestogen with antimineralocorticoid properties: a short review.
    Oelkers W.
    Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):255-61. PubMed ID: 15134826
    [Abstract] [Full Text] [Related]

  • 36. Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention.
    Fruzzetti F, Lazzarini V, Ricci C, Quirici B, Gambacciani M, Paoletti AM, Genazzani AR.
    Contraception; 2007 Sep 31; 76(3):190-4. PubMed ID: 17707715
    [Abstract] [Full Text] [Related]

  • 37. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May 31; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 38. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
    Milsom I, Lete I, Bjertnaes A, Rokstad K, Lindh I, Gruber CJ, Birkhäuser MH, Aubeny E, Knudsen T, Bastianelli C.
    Hum Reprod; 2006 Sep 31; 21(9):2304-11. PubMed ID: 16763008
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
    Duijkers IJ, Klipping C, Grob P, Korver T.
    Eur J Contracept Reprod Health Care; 2010 Oct 31; 15(5):314-25. PubMed ID: 20695770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.